Hsieh J Y, Lin C, Matuszewski B K
Department of Drug Metabolism, Merck Research Laboratories, West Point, PA 19486.
J Chromatogr B Biomed Appl. 1994 Nov 18;661(2):307-12. doi: 10.1016/0378-4347(94)00367-x.
A fully automated HPLC assay has been developed and validated for the quantitation of verlukast, a leukotriene D4 antagonist, in human plasma. An upgraded Zymate I robotic system was utilized to perform protein precipitation and on-line injection followed by reversed-phase HPLC with fluorescence detection. Inter-day accuracy and precision were 100.8 and 4.6%, respectively, for the low quality control standards (0.125 microgram/ml). The automated robotic method was shown to be more efficient and accurate than the manual method.
已开发并验证了一种全自动高效液相色谱(HPLC)分析法,用于定量测定人血浆中的白三烯D4拮抗剂 verlukast。使用升级后的Zymate I机器人系统进行蛋白质沉淀和在线进样,随后进行反相高效液相色谱荧光检测。低质量控制标准品(0.125微克/毫升)的日间准确度和精密度分别为100.8%和4.6%。结果表明,自动化机器人方法比手动方法更高效、准确。